Global Insulin Drug and Delivery Technologies Market Professional Survey Report 2019
Insulin is a protein hormone that is used as a medication to treat high blood glucose. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states. It is also used along with glucose to treat high blood potassium levels. Typically it is given by injection under the skin, but some forms may also be used by injection into a vein or muscle.
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.
The global Insulin Drug and Delivery Technologies market was valued at 36000 million US$ in 2018 and will reach 67500 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2019-2025.
This report focuses on Insulin Drug and Delivery Technologies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Drug and Delivery Technologies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Drug and Delivery Technologies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin Drug and Delivery Technologies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Segment by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles, leading to a steady market for these technologies. Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future.
The global Insulin Drug and Delivery Technologies market was valued at 36000 million US$ in 2018 and will reach 67500 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2019-2025.
This report focuses on Insulin Drug and Delivery Technologies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Drug and Delivery Technologies market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Drug and Delivery Technologies in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin Drug and Delivery Technologies manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Sanofi
Eli Lilly and Company
Biocon
Julphar
Ypsomed
Becton, Dickinson and Company
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Insulin Syringes
Insulin Vials
Insulin Pens
Insulin Pumps
Segment by Application
Diabetes Mellitus Type 1
Diabetes Mellitus Type 2
Gestational Diabetes
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
